CONTEXT: In August 1998, the US Food and Drug Administration licensed the first vaccine against rotavirus, the most important cause of severe childhood diarrhea. Fourteen months later, amid intense media activity, the vaccine was withdrawn after an association was found... View more
1. Kapikian AZ, Chanock RM. Rotaviruses. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. 3rd ed. vol 2. New York; NY: Raven Press; 1996: 1657-1708.
2. Estes MK. Rotaviruses and their replication. In: Fields BN, Knipe DM, Howley PM, et al, eds. Fields Virology. 3rd ed. Vol 2. New York, NY: Raven Press; 1996: 1625-1655.
3. Institute of Medicine. The prospects of immunizing against rotavirus. In: New Vaccine Development: Diseases of Importance in Developing Countries. Vol 2. Washington, DC: National Academy Press; 1986.
5. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 1999;48(RR2):1-20.
6. US Bureau of the Census. World population profile 1996, table A-5. Available at: http://www.census .gov/ipc/www/wp96file.html. Accessed May 8, 2001. Accessibility verified February 18, 2002.
7. Vesikari T, Kapikian AZ, Delem A, Zissis G. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children. J Infect Dis. 1986;153:832-839.
8. Gotherfors L, Wadell G, Juto P, et al. Prolonged efficacy of rhesus rotavirus vaccine in Swedish children. J Infect Dis. 1989;159:753-757.
9. LeBaron CW, Lew J, Glass RI, Weber JM, RuizPalacios GM. Annual rotavirus epidemic patterns in North America: results of a 5-year retrospective survey of 88 centers in Canada, Mexico, and the United States. JAMA. 1990;264:983-988.